Company / News

Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)

Guidance for Industry and Food and Drug Administration Staff

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19 for the duration of the COVID-19 public health emergency.

download whitepaper

Related News

Cottle Leads Voler Systems Worldwide Sales...

Technology industry veteran brings 25 years of experience to growing...

Non-invasive hemodynamic monitoring system

"We used Voler to help us design and develop a...

Project Management Resources

Here is more information to help you become highly successful...

Newsletter Sign Up
chat-icon
clse-1
Get Expert Consulting

Voler is really good at identifying risks and finding the best way to do a project on-time, on spec, and easy to manufacture.